Search research articles
Contact Us
Filters
Showing results (121-130 of 124) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 124 results.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitors
Matthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
JNCI Cancer Spectrum
|
July 23, 2025
Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatment
P Travis Courtney, Jesus E Juarez Casillas, Eulanca Y Liu, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease
David A Candito, Vladimir Simov, Anmol Gulati, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 124) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 124 results.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitors
Matthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
JNCI Cancer Spectrum
|
July 23, 2025
Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatment
P Travis Courtney, Jesus E Juarez Casillas, Eulanca Y Liu, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease
David A Candito, Vladimir Simov, Anmol Gulati, et al.
Page
of 13